These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 13839681)

  • 21. [Comparative experimental studies on 5-methyl-3-sulfanilamido-isoxazole, other sulfanilamides and antibiotics].
    FUST B; BOEHNI E
    Schweiz Med Wochenschr; 1962 Dec; 92():1599-604. PubMed ID: 13945938
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of the chemotherapeutic effectiveness of sulfamethazine and sulfisoxazole in experimental infections.
    KISER JS; DE MELLO GC; WATERS MK; CLEMENTE J; WILLIAMS JH
    Antibiot Chemother (Northfield); 1952 Aug; 2(8):427-31. PubMed ID: 24542065
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of gantrisin on the prothrombin time.
    PISCIOTTA AV; HINZ JE; HIRSCHBOECK JS
    J Urol; 1954 Jun; 71(6):768-70. PubMed ID: 13163987
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of gantrisin on prothrombin activity.
    SHOEMAKER EH; YOW EM
    J Urol; 1954 Jul; 72(1):87-8. PubMed ID: 13164001
    [No Abstract]   [Full Text] [Related]  

  • 25. Syrup sulfisoxazole.
    WOMBLE JM; BROWN AE; RUDOLPH HS
    Med Techn Bull; 1953; 4(5):201-2. PubMed ID: 13098644
    [No Abstract]   [Full Text] [Related]  

  • 26. NEW and nonofficial drugs; sulfisoxazole.
    J Am Med Assoc; 1953 Feb; 151(9):739. PubMed ID: 13011089
    [No Abstract]   [Full Text] [Related]  

  • 27. IN VITRO SENSITIVITY OF ESCHERICHIA COLI TO SULFONAMIDES.
    GLANTZ PJ
    Cornell Vet; 1965 Jan; 55():9-18. PubMed ID: 14284453
    [No Abstract]   [Full Text] [Related]  

  • 28. NEW and nonofficial drugs; sulfisoxazole diethanolamine.
    J Am Med Assoc; 1953 Feb; 151(9):740. PubMed ID: 13011090
    [No Abstract]   [Full Text] [Related]  

  • 29. The determination of sulfisoxazole and sulfadimethoxine in blood and plasma.
    ROSENTHAL HL; JUD L
    J Lab Clin Med; 1959 Sep; 54():461-6. PubMed ID: 14439052
    [No Abstract]   [Full Text] [Related]  

  • 30. Preliminary report on the lowering of prothrombin by gantrisin.
    SILBERG S; BRUNO C; KEESAL S; MICELI S
    J Urol; 1953 Nov; 70(5):796-801. PubMed ID: 13109936
    [No Abstract]   [Full Text] [Related]  

  • 31. COMPARISON BETWEEN THE RATE CONSTANTS FOR ACETYLATION OF SULFONAMIDES IN VIVO AND UW PARTITION COEFFICIENT.
    NELSON E
    J Med Pharm Chem; 1962 Jan; 5():211-4. PubMed ID: 14046611
    [No Abstract]   [Full Text] [Related]  

  • 32. COMPARISON BETWEEN THE RATE CONSTANTS FOR ACETYLATION OF SULFONAMIDES IN VIVO AND O-W PARTITION COEFFICIENT.
    NELSON E
    J Med Pharm Chem; 1962 Jan; 5():211-4. PubMed ID: 14047424
    [No Abstract]   [Full Text] [Related]  

  • 33. Observations on the use of sulfisoxazole (gantrisin) in 1000 consecutive patients, with particular reference to the frequency of undesirable side effects.
    YOW EM
    Am Pract Dig Treat; 1953 Aug; 4(8):521-5. PubMed ID: 13080563
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effect of sulfisoxazole on South American blastomycosis].
    SAMPAIO SA; DA LACAZ CS; BOLOGNANI FILHO H
    Rev Assoc Med Bras; 1955 Oct; 2(1):33-6. PubMed ID: 13298071
    [No Abstract]   [Full Text] [Related]  

  • 35. Kinetics of sulfisoxazole acetylation and excretion in humans.
    NELSON E; O'REILLY I
    J Pharmacol Exp Ther; 1960 Aug; 129():368-72. PubMed ID: 14426447
    [No Abstract]   [Full Text] [Related]  

  • 36. Sulfisoxazole (gantrisin): concentration in plasma and diffusion into the cerebrospinal fluid.
    BOGER WP; STRICKLAND SC; GYLFE JM
    J Am Geriatr Soc; 1957 May; 5(5):520-9. PubMed ID: 13438670
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical use of a sulfisoxazole emulsion.
    TOWNSEND EH
    Ann N Y Acad Sci; 1957 Oct; 69(3):404-7. PubMed ID: 13488270
    [No Abstract]   [Full Text] [Related]  

  • 38. New Ni(II)-sulfonamide complexes: synthesis, structural characterization and antibacterial properties. X-ray diffraction of [Ni(sulfisoxazole)2(H2O)4].2H2O and [Ni(sulfapyridine)2].
    Mondelli M; Bruné V; Borthagaray G; Ellena J; Nascimento OR; Leite CQ; Batista AA; Torre MH
    J Inorg Biochem; 2008 Feb; 102(2):285-92. PubMed ID: 17976730
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Studies on the shaking culture of Mycobacterium tuberculosis. III. On the evaluation of the antitubercular action of sulfonamides].
    HATA T
    Kekkaku; 1963 Mar; 38():111-6. PubMed ID: 13960931
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical use of a lipid emulsion of sulfisoxazole.
    KRUGMAN S
    Ann N Y Acad Sci; 1957 Oct; 69(3):399-403. PubMed ID: 13488269
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.